River Ridge, LA, United States of America

Cheryl Anne Nickerson

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: Washington University, The Administrators of the Tulane Educational Fund, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2000-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cheryl Anne Nickerson. Retrieved from https://idiyas.com/inventor/cheryl-anne-nickerson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 116(Granted Patents)


Location History:

  • Chesterfield, MO (US) (2000)
  • River Ridge, LA (US) (2002 - 2007)

Company Filing History:


Years Active: 2000-2007

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Cheryl Anne Nickerson: Innovator in Infectious Disease Research

Introduction

Cheryl Anne Nickerson is a prominent inventor based in River Ridge, LA (US). She has made significant contributions to the field of infectious disease research, holding a total of 4 patents. Her work focuses on innovative methods for studying microbial infectivity and chemosensitivity, which have important implications for medical science.

Latest Patents

One of her latest patents is titled "Methods for modeling infectious disease and chemosensitivity in cultured cells and tissues." This invention provides methods for utilizing optimized suspension culture to examine the infectivity of pathogenic organisms in human cells and tissues. It also includes methods using a rotating wall vessel to predict chemosensitivity of cells to toxins and chemotherapeutic agents. These culture conditions enhance cellular differentiation and the formation of three-dimensional aggregates that closely resemble in vivo tissue. This innovative approach allows for better analysis of host-pathogen interactions and chemosensitivity.

Another notable patent is "Recombinant vaccines comprising immunogenic attenuated bacteria having RpoS positive phenotype." This patent discloses attenuated immunogenic bacteria with an RpoS phenotype, which can be used in vaccines and as delivery vehicles for genes. The methods for preparing these vaccine delivery vehicles are also outlined, showcasing her commitment to advancing vaccine technology.

Career Highlights

Cheryl has worked with esteemed institutions such as Washington University and the United States Government, represented by the Department of Veterans Affairs. Her research has significantly impacted the understanding of infectious diseases and the development of new therapeutic strategies.

Collaborations

Throughout her career, Cheryl has collaborated with notable individuals in her field, including Roy Curtiss III and Timothy Grant Hammond. These partnerships have further enriched her research and contributed to her innovative work.

Conclusion

Cheryl Anne Nickerson is a trailblazer in the field of infectious disease research, with a focus on innovative methods and vaccine development. Her contributions through her patents and collaborations continue to influence the scientific community and improve public health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…